Nelfinavir Mesylate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Nelfinavir Mesylate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 14, 1997. In 2024, Medicare Part D spent $705K on Nelfinavir Mesylate across 515 claims for 64 beneficiaries.
Nelfinavir Mesylate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $9.72 to $9.72 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$9.72 – $9.72
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing NELFINAVIR MESYLATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIRACEPT 625 MG TABLET | $9.7224 per EA | — |
Frequently Asked Questions
What is Nelfinavir Mesylate used to treat?
Nelfinavir Mesylate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Nelfinavir Mesylate?
In 2024, Medicare Part D spent $705K on Nelfinavir Mesylate across 515 claims for 64 beneficiaries.
How many Nelfinavir Mesylate products are on the market?
The Nelfinavir Mesylate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Nelfinavir Mesylate?
NADAC reference prices for Nelfinavir Mesylate range from $9.7224 to $9.7224 per EA.
Which manufacturers make Nelfinavir Mesylate?
1 manufacturer lists Nelfinavir Mesylate in NADAC. Ranked by number of NDCs, the largest are AGOURON (1).